There are ALL treatments on the market comprising formulations of L-asparaginase obtained from Escherichia coli and Erwinia chrysanthemi and there is a formulation of polyethylene glycol-conjugated L-asparaginase [8,9]. The gene discussed is ASPG; the disease is acute lymphoblastic leukemia.